Amsurg (AMSG) Tops Q2 EPS by 13c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
AmSurg Reports Second-Quarter Adjusted Diluted EPS of $0.97 and Diluted EPS of $0.65
August 4, 2015 4:00 PM EDTIncreases 2015 Financial Guidance
Announces Acquisition of Bay Area Anesthesia, LLC in Tampa
NASHVILLE, Tenn.--(BUSINESS WIRE)-- AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the second quarter ended June 30, 2015. The Companys results for the quarter included:
Net revenues of $642.0 million, an increase of 131% from the second quarter of 2014; Net earnings from continuing operations attributable to AmSurg common shareholders of $31.4 million. Adjusted net earnings of $49.9 million increased 131% from the second quarter of 2014;... More